Specialized Medical Company (TADAWUL:4019)

TADAWUL:4019 Income Statement

Financials in millions SAR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue	1,469	1,440	1,368	1,209	1,053
Revenue Growth (YoY)	7.39%	5.24%	13.18%	14.77%	-
Cost of Revenue	1,094	1,055	1,019	930	824.89
Gross Profit	375.09	384.85	348.96	278.66	228.24
Selling, General & Admin	181.24	154.55	134.38	150.91	159.04
Operating Expenses	181.24	154.55	134.38	150.91	159.04
Operating Income	193.84	230.3	214.58	127.75	69.2
Interest Expense	-44.47	-44.98	-48.46	-29.82	-18.89
Other Non Operating Income (Expenses)	11.66	10.62	8.52	9.13	8.92
EBT Excluding Unusual Items	161.03	195.95	174.65	107.05	59.24
Gain (Loss) on Sale of Assets	-2.29	-2.29	0.05	0.06	0.05
Pretax Income	158.74	193.66	174.7	107.12	59.29
Income Tax Expense	7.66	8.44	6	4.15	3.32
Net Income	151.07	185.22	168.7	102.96	55.97
Net Income to Common	151.07	185.22	168.7	102.96	55.97
Net Income Growth	-10.45%	9.79%	63.84%	83.97%	-
Shares Outstanding (Basic)	250	250	85	85	85
Shares Outstanding (Diluted)	250	250	85	85	85
Shares Change (YoY)	194.12%	194.12%	-	-	-
EPS (Basic)	0.60	0.74	1.98	1.21	0.66
EPS (Diluted)	0.60	0.74	1.98	1.21	0.66
EPS Growth	-69.55%	-62.67%	63.84%	83.97%	-
Free Cash Flow	288.52	289.52	160.53	116.6	-159.38
Free Cash Flow Per Share	1.15	1.16	1.89	1.37	-1.88
Gross Margin	25.53%	26.73%	25.51%	23.05%	21.67%
Operating Margin	13.20%	16.00%	15.69%	10.57%	6.57%
Profit Margin	10.28%	12.87%	12.33%	8.52%	5.31%
Free Cash Flow Margin	19.64%	20.11%	11.73%	9.65%	-15.13%
EBITDA	254.74	288.77	273.08	202.59	141.55
EBITDA Margin	17.34%	20.06%	19.96%	16.76%	13.44%
D&A For EBITDA	60.89	58.47	58.49	74.85	72.35
EBIT	193.84	230.3	214.58	127.75	69.2
EBIT Margin	13.20%	16.00%	15.69%	10.57%	6.57%
Effective Tax Rate	4.83%	4.36%	3.44%	3.88%	5.60%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.